Eurobio Scientific

EurobioPlex

EurobioPlex SARS-CoV-2 Fast-SVT Screening and VOC typing

EBX-048
The EurobioPlex SARS-CoV-2 Fast-SVT test is a real-time polymerase chain reaction (RT-PCR) assay which, in a single test, identifies the prevalence of SARS-CoV-2 and distinguishes be-tween the K417N (Omicron variant BA.x and BA.2 screening), V213G (BA.2 sublineage of Omi-cron variant screening) and L452R (Delta variant screening) mutations in a qualitative manner. The presence of the V213G makes it possible to differentiate the BA.2 sub-lineage of the Omi-cron variant. The presence of this 3 mutations indicate the BA.4 or BA.5 sub-lineages.

You have questions or want more informations?

  • REF : EBX-048
  • Pathogens : SARS-CoV-2 / K417N Mutation / L452R Mutation / V213G Mutation / Housekeeping gene
  • Shipment : Dry ice
  • Storage at -20 °C
SARS CoV-2 K417N Mutation L452R Mutation V213GMutation
Analytical Sensitivity WHO : 3,2 copies / µl 5 copies / µl 5 copies / µl 10 copies / µl
Diagnostic sensitivity > 99% > 99% > 99% > 99%
Diagnostic specificity > 99% > 99% > 99% > 99%

Not a member yet? Register now

You may also like

Our Products & Services

For the field of transplantation, the group produces reagents and software for transplant matching and chimerism monitoring and culture media for cornea graft transplants.

Eurobio Scientific manufactures prognostic genetics tests for breast cancer and prostatic cancer.

The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions.

To support the research and development field, Eurobio Scientific has a broad portfolio in Life Sciences products including cell culture media and quality controls.

en_GB
Scroll to Top